Lakefront Biotherapeutics (LKFT) Current Assets (2014 - 2026)
Lakefront Biotherapeutics (LKFT) posted quarterly Current Assets of $3.6 billion for Q1 2026, down 1.89% year-over-year from $3.7 billion in Q1 2025, and little changed quarter-over-quarter from $3.6 billion in Q4 2025.
Lakefront Biotherapeutics (LKFT) Current Assets (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Current Assets for 13 consecutive years, with $3.6 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 1.89% year-over-year to $3.6 billion; the TTM figure through Mar 2026 stood at $3.6 billion (down 1.89% YoY), while the FY2025 annual figure was $3.6 billion, changed 0.45% from the prior year.
- Current Assets was little changed at $3.6 billion in Q1 2026 per LKFT's latest filing, from $3.6 billion in the prior quarter.
- Across five years, Current Assets topped out at $5.3 billion in Q1 2022 and bottomed at $3.6 billion in Q4 2024.
- Historically, Current Assets has averaged $4.0 billion across 5 years, with a median of $3.9 billion in 2024.
- Annual changes were most pronounced in 2022 — Current Assets decreased 22.28% — and 2025, when it climbed 0.45%.
- Lakefront Biotherapeutics' Current Assets stood at $4.3 billion in 2022, then retreated by 3.88% to $4.2 billion in 2023, then retreated by 14.11% to $3.6 billion in 2024, then gained by 0.45% to $3.6 billion in 2025, then retreated by 0.04% to $3.6 billion in 2026.
- Business Quant data shows LKFT's Current Assets at $3.6 billion in Q1 2026, $3.6 billion in Q4 2025, and $3.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Lakefront Biotherapeutics | 1.81 Bn | -1.68 Bn | 1.97 Mn | 3.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.58 Bn |
| Dec 31, 2025 | 3.58 Bn |
| Sep 30, 2025 | 3.70 Bn |
| Jun 30, 2025 | 3.68 Bn |
| Mar 31, 2025 | 3.65 Bn |
| Dec 31, 2024 | 3.57 Bn |
| Sep 30, 2024 | 3.91 Bn |
| Mar 31, 2024 | 4.11 Bn |
| Dec 31, 2023 | 4.15 Bn |
| Sep 30, 2023 | 4.31 Bn |
| Mar 31, 2023 | 4.46 Bn |
| Dec 31, 2022 | 4.32 Bn |
| Mar 31, 2022 | 5.33 Bn |
| Dec 31, 2021 | 5.56 Bn |
| Jun 30, 2021 | 6.18 Bn |
| Dec 31, 2020 | 6.40 Bn |
| Jun 30, 2020 | 6.19 Bn |
| Mar 31, 2020 | 6.38 Bn |
| Dec 31, 2019 | 6.49 Bn |
| Sep 30, 2019 | 6.29 Bn |